The trading price of Supernus Pharmaceuticals Inc (NASDAQ:SUPN) floating higher at last check on Wednesday, August 07, closing at $33.00, 18.36% higher than its previous close.
The company’s P/E ratio in the trailing 12-month period was 373.73. In examining the 52-week price action we see that the stock hit a 52-week high of $35.44 and a 52-week low of $21.99. Over the past month, the stock has gained 23.64% in value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Supernus Pharmaceuticals Inc, whose market valuation is $1.81 billion at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 0.43 per share this quarter, however they have predicted annual earnings per share of 1.75 for current year and 2.1 for next year.
Analysts have forecast the company to bring in revenue of 153.4M for the current quarter, with the likely lows of 145.8M and highs of 160.98M. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 600.12M.
On the technical side, indicators suggest SUPN has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 100% Buy.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 221.14, which symbolizes a positive outlook. A quick review shows that SUPN’s price is currently 12.40% off the SMA20 and 18.87% off the SMA50. The RSI metric on the 14-day chart is currently showing 71.13, and weekly volatility stands at 3.41%. When measured over the past 30 days, the indicator reaches 3.25%. Supernus Pharmaceuticals Inc (NASDAQ:SUPN)’s beta value is currently sitting at 0.88, while the Average True Range indicator is currently displaying 1.34.
To see how Supernus Pharmaceuticals Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: SUPN stock’s performance was 18.36% at last check in today’s session, and 2.33% in the past year. Supernus Pharmaceuticals Inc has a P/E ratio of 373.73.
An evaluation of the daily trading volume of Supernus Pharmaceuticals Inc (NASDAQ:SUPN) indicates that the 3-month average is 609.94K.
Currently, records show that 54.72 million of the company’s shares remain outstanding. The insiders hold 4.26% of outstanding shares, whereas institutions hold 103.09%. However, since the stock’s price has seen 14.03% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
